Skip to main content
Equibles

RHUMBLINE ADVISERS

Position in CGEM — Cullinan Therapeutics, Inc.

CIK 1115418 BOSTON, MA
Back to CGEM Full portfolio

Position in CGEM

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$1,437,315
+$477,913 QoQ
Shares Held
78,930
+16.9% QoQ
Ownership
0.123%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#63
of 183 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority Sole 17% Shared 0% None 83%

Common Shares in CGEM Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

RHUMBLINE ADVISERS holds $1,414,750,230 across 329 Biotechnology names. CGEM ranks #116 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 396,380 $196,893,837
2 REGN
Regeneron Pharmaceuticals, Inc.
 157,794 $98,390,870
3 MRNA
Moderna, Inc.
 809,853 $56,714,005
4 ALNY
Alnylam Pharmaceuticals, Inc.
 165,579 $49,844,246
5 INCY
Incyte Corp
 428,533 $48,578,500
6 RVMD
Revolution Medicines, Inc.
 226,008 $42,326,778
7 ROIV
Roivant Sciences Ltd.
 1,178,789 $41,717,342
8 JAZZ
Jazz Pharmaceuticals plc
 163,018 $39,282,447

All Filings in CGEM

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,437,315 78,930
2026-03-31 $959,402 67,516
2025-12-31 $695,934 67,240
2025-09-30 $425,827 71,809
2025-06-30 $558,010 74,105
2025-03-31 $540,028 71,338
2024-12-31 $830,773 68,208
2024-09-30 $1,052,276 62,860
2024-06-30 $947,881 54,351
2024-03-31 $795,802 46,702
2023-12-31 $465,988 45,730
2023-09-30 $409,412 45,239
2023-06-30 $497,402 46,227
2023-03-31 $522,681 51,093
2022-12-31 $492,611 46,693
2022-09-30 $586,925 45,782
2022-06-30 $552,836 43,123
2022-03-31 $335,511 32,045
2021-12-31 $472,158 30,600
2021-09-30 $700,234 31,025
2021-06-30 $386,945 15,027
2021-03-31 $482,705 11,584